Literature DB >> 25196430

The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis.

Xiao-Yi Jia1, Yan Chang2, Xiao-Jing Sun2, Xing Dai2, Wei Wei3.   

Abstract

Prostaglandin E2 (PGE2), a very potent lipid mediator produced from arachidonic acid (AA) through the action of cyclooxygenase (COX) enzymes, is implicated in the regulation of dendritic cell (DC) functions such as differentiation ability, cytokine-producing capacity, Th-cell polarizing ability, migration and maturation. DCs are the most potent antigen-presenting cells and play major roles in both the induction of primary immune responses and tolerance. It is well established that PGE2 functions significantly in the pathogenesis of rheumatoid arthritis (RA). Although the role of PGE2 in RA has been studied extensively, the effects of PGE2 on DC biology and the role of DCs in RA have not become the focus of investigation until recently. Here, we summarize the latest progress in PGE2 research with respect to DC functions, as well as the role of PGE2 receptor signaling of DCs in the pathogenesis of RA.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dendritic cells; Differentiation; Migration; PGE2; Rheumatoid arthritis; Th cell polarization

Mesh:

Substances:

Year:  2014        PMID: 25196430     DOI: 10.1016/j.intimp.2014.08.024

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

1.  Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.

Authors:  Kirsten M Hooper; Jui-Hung Yen; Weimin Kong; Kate M Rahbari; Ping-Chang Kuo; Ana M Gamero; Doina Ganea
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

Review 2.  The function of myeloid dendritic cells in rheumatoid arthritis.

Authors:  Mary Beth Yu; William H R Langridge
Journal:  Rheumatol Int       Date:  2017-02-24       Impact factor: 2.631

3.  Recent Advances in GPCR-Regulated Leukocyte Responses during Acute Cardiac Injury.

Authors:  Tapas K Nayak; Douglas G Tilley
Journal:  Curr Opin Physiol       Date:  2020-09-15

4.  Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis.

Authors:  Yanyan Zhang; Zhaoju Gao; Shushu Chao; Wenjuan Lu; Pingping Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis.

Authors:  Yang Wang; Chen-Chen Han; Dongqian Cui; Ting-Ting Luo; Yifan Li; Yuwen Zhang; Yang Ma; Wei Wei
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  TNF-α impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes.

Authors:  Yu Tai; Bei Huang; Pai-Pai Guo; Zhen Wang; Zheng-Wei Zhou; Man-Man Wang; Han-Fei Sun; Yong Hu; Sheng-Lin Xu; Ling-Ling Zhang; Qing-Tong Wang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2021-04-15       Impact factor: 6.150

Review 7.  Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors:  Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-26

Review 8.  EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

Authors:  Madison N Sluter; Ruida Hou; Lexiao Li; Nelufar Yasmen; Ying Yu; Jiawang Liu; Jianxiong Jiang
Journal:  J Med Chem       Date:  2021-08-05       Impact factor: 8.039

9.  Effects of intra-articular SHINBARO treatment on monosodium iodoacetate-induced osteoarthritis in rats.

Authors:  Won Kyung Kim; Hwa-Jin Chung; Yuna Pyee; Tae Jun Choi; Hyen Joo Park; Ji-Young Hong; Joon-Shik Shin; Jin Ho Lee; In-Hyuk Ha; Sang Kook Lee
Journal:  Chin Med       Date:  2016-04-11       Impact factor: 5.455

10.  Corticosterone suppresses IL-1β-induced mPGE2 expression through regulation of the 11β-HSD1 bioactivity of synovial fibroblasts in vitro.

Authors:  Bo Wei; Zhaobo Zhu; Min Xiang; Lijun Song; Weixiong Guo; Hao Lin; Guangsheng Li; Rong Zeng
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.